PhM-754

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePhM-754
Drug Alias Namebacteriophage lysin (PhagoMed Biopharma)lysin enzyme therapy (PhagoMed Biopharma)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiontech Austria Beteiligungen Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiontech Austria Beteiligungen Gmbh
Active IndicationsN/A
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A